Profile data is unavailable for this security.
About the company
Embracing Future Holdings Ltd, formerly Biolidics Limited, is a precision medicine medical technology company. Its principal activities are technology development, technology transfer, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services and investment holding. Its segments are Cancer, Infectious diseases, Laboratory services, and Corporate segments. Its Cancer and infectious diseases segments involve identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship networks and direct customers in the cancer field, and the infectious diseases field. The Laboratory services segment involves business, operation, and provision of laboratory services to customers. The laboratory has regulatory approval from Singapore’s Ministry of Health for testing for COVID-19 in Singapore.
- Revenue in SGD (TTM)784.00k
- Net income in SGD-3.19m
- Incorporated2009
- Employees15.00
- LocationEmbracing Future Holdings Ltd18 Howard Road#11-09 Novelty BizCentre,SINGAPORE 369585SingaporeSGP
- Phone+65 64820668
- Fax+65 64820778
- Websitehttps://www.ebfholdings.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wellell Inc | 96.46m | 5.59m | 93.33m | 535.00 | 16.79 | 0.9483 | 9.59 | 0.9676 | 1.37 | 1.37 | 23.60 | 24.20 | 0.7533 | 2.78 | 6.25 | -- | 4.40 | 4.07 | 5.47 | 5.35 | 46.15 | 42.35 | 5.85 | 5.30 | 1.99 | -- | 0.1184 | 56.36 | -9.84 | 3.23 | -24.27 | 5.56 | 13.42 | 12.20 |
| SDI Ltd | 99.37m | 10.95m | 94.69m | 300.00 | 8.65 | 1.02 | 6.18 | 0.953 | 0.1023 | 0.1023 | 0.9287 | 0.8638 | 0.7833 | 1.45 | 5.43 | -- | 8.63 | 7.81 | 10.31 | 9.29 | 62.85 | 59.86 | 11.02 | 9.06 | 1.62 | 28.73 | 0.1448 | 42.64 | -0.7392 | 10.38 | 16.69 | 23.47 | 13.53 | 12.94 |
| Create Medic Co Ltd | 110.39m | 5.79m | 95.73m | 1.00k | 14.99 | 0.6274 | 9.20 | 0.8673 | 81.52 | 81.52 | 1,540.66 | 1,947.78 | 0.6776 | 1.81 | 4.29 | -- | 3.55 | 3.01 | 4.07 | 3.52 | 44.02 | 44.00 | 5.24 | 4.51 | 4.81 | 35.35 | 0.0439 | 59.80 | 4.51 | 4.69 | -15.12 | 1.59 | 1.66 | 3.99 |
| Embracing Future Holdings Ltd | 784.00k | -3.19m | 98.81m | 15.00 | -- | 51.18 | -- | 126.03 | -0.0031 | -0.0035 | 0.0008 | 0.0011 | 0.2931 | 108.55 | 4.43 | -- | -119.33 | -56.05 | -418.62 | -82.95 | 23.85 | 36.68 | -407.14 | -167.32 | 0.3501 | -81.64 | 0.5026 | -- | 183.03 | -11.43 | -110.83 | -- | -61.24 | -- |
